• Home
  • Diagnosis & Assessment
    • I. Accurate Measurement of Blood Pressure
    • II. Criteria for Diagnosis of Hypertension and Guidelines for Follow-up
    • III. Routine and optional laboratory tests for the investigation of patients with hypertension
    • IV. Assessment of overall cardiovascular risk in hypertensive patients
    • XVI. Assessment for renovascular hypertension
    • XVIII. Assessment for endocrine hypertension
    • Supplementary Tables
  • Prevention & Treatment
    • V. Global vascular protection therapy for adults with hypertension without compelling indications for specific agents
    • VI. Health behaviour management
    • VII. Indications for drug therapy for adults with hypertension without
    • VIII. Choice of therapy for adults with hypertension without compelling indications for specific agents
    • IX. Treatment of hypertension in association with diabetes mellitus
    • X. Treatment of hypertension in association with nondiabetic chronic kidney disease
    • XI. Treatment of hypertension in association with stroke
    • XII. Treatment of hypertension in association with ischemic heart disease
    • XIII. Treatment of hypertension in association with heart failure
    • XIV. Treatment of hypertension in association with left ventricular hypertrophy
    • XV. Resistant hypertension
    • XVII. Treatment of hypertension in association with renovascular disease
    • XIX. Treatment of secondary hypertension due to endocrine causes
    • XX. Adherence strategies for patients
    • Supplementary Tables
  • Professional Resources
    • Professional Resources
    • Patient Resources
  • Ressources françaises
    • Ressources françaises
    • Ressources pour les patients
  • About
    • Hypertension Canada Guidelines
    • Process Overview
    • References

©2022 Hypertension Canada. All rights reserved. Unauthorized use prohibited. Hypertension Canada does not provide medical advice, diagnosis or treatment.